Orano Projects

Description

Orano Med Theranostics Orano Med has developed new processes for producing high‑purity lead‑212, a rare radioactive isotope. Lead‑212 is currently at the heart of promising research projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells.

We are seeking a highly motivated Process Development Scientist with expertise in radiopharmaceutical development to join our CMC team. The successful candidate will design, execute, and analyze studies and create reports for R&D CMC to support the development of novel radiopharmaceutical compounds. This role offers an opportunity to contribute to groundbreaking therapies and collaborate with cross‑functional teams to advance our pipeline toward clinical trials.

Key Responsibilities

• Design, conduct and optimize R&D studies to characterize radiopharmaceutical compounds.
• Analyze, interpret, and troubleshoot complex datasets.
• Scale up, write reports and transfer processes from R&D to GMP manufacturing teams.
• Review and further develop & refine existing processes.
• Collaborate with cross‑functional teams to review protocols, batch records, formulation records, deviations and other related documents.
• Maintain accurate records of experiments and ensure data integrity in accordance with company policies.
• Stay current with advancements in radiopharmaceutical science and contribute to the development of innovative research strategies.
• Other duties, as needed.

Avantages

• Competitive compensation
• Health, Dental, and Vision insurance – with generous employer contributions
• 401(k) with employer matching and contribution amounts
• Life insurance and Short‑ and Long‑Term Disability insurance provided by the company
• Generous Paid Time Off and holiday schedules
• Numerous Training and Development opportunities
• and more.

Groupe Orano

Present in the United States for 60 years, Orano USA is a leading technology and services provider to the U.S. commercial and federal markets.

Orano’s activities in the U.S. include developing uranium enrichment facility in Oak Ridge, TN; packages and transportation of uranium & nuclear fuel assemblies; fabricating & installing used nuclear fuel dry storage canisters and casks, conducting pool‑to‑pad used nuclear fuel transfers; providing solutions to the National Labs and to the Dept of Energy; and supplying U.S. nuclear energy utilities with uranium, conversion, and enrichment services.

In the nuclear medicine field, Orano Med is at the forefront of research in nuclear medicine and is developing a new generation of targeted therapies against cancer using the unique properties of lead‑212.

In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and to complete the required employment eligibility verification form upon hire.

This position requires a pre‑employment background check and drug screening.

Orano is an Equal Opportunity Employer. Orano and all subsidiaries abide by applicable legal requirements. We ensure that all personnel actions such as recruitment, compensation, career development, benefits, and company‑sponsored training are administered without regard to race, color, religion, sex, national origin, age, disability, sexual orientation, protected veteran, or other protected status.